Abstract

Adrenal insufficiency is a rare, but potentially fatal medical condition. In children, the cause is most commonly congenital and in recent years a growing number of causative gene mutations have been identified resulting in a myriad of syndromes that share adrenal insufficiency as one of the main characteristics. The evolution of adrenal insufficiency is dependent on the variant and the particular gene affected, meaning that rapid and accurate diagnosis is imperative for effective treatment of the patient. Common practice is for candidate genes to be sequenced individually, which is a time-consuming process and complicated by overlapping clinical phenotypes. However, with the availability, and increasing cost effectiveness of whole-exome sequencing, there is the potential for this to become a powerful diagnostic tool. Here, we report the results of whole-exome sequencing of 43 patients referred to us with a diagnosis of familial glucocorticoid deficiency (FGD) who were mutation negative for MC2R, MRAP, and STAR the most commonly mutated genes in FGD. WES provided a rapid genetic diagnosis in 17/43 sequenced patients, for the remaining 60% the gene defect may be within intronic/regulatory regions not covered by WES or may be in gene(s) representing novel etiologies. The diagnosis of isolated or familial glucocorticoid deficiency was only confirmed in 3 of the 17 patients, other genetic diagnoses were adrenal hypo- and hyperplasia, Triple A, and autoimmune polyendocrinopathy syndrome type I, emphasizing both the difficulty of phenotypically distinguishing between disorders of PAI and the utility of WES as a tool to achieve this.

Highlights

  • The hypothalamic–pituitary–adrenal (HPA) axis is essential in the physiological response to stress and illness

  • Similar numbers of variants were called from 43 exomes combined, after confidence filtration the first analysis pipeline produced a total of 393,015 variants in 20,327 genes with many variants being common between samples whereas the second had 393,262 variants in 20,249 genes. 400 and 358 variants within our 20 Primary adrenal insufficiency (PAI) genes (Table 1) were called by first and second pipelines, respectively, and after further filtration (Figure 2) the following results were obtained

  • The frameshift variants found in CDKN1C and Nuclear receptor subfamily 5A1 (NR5A1) in patients 34–37 proved to be sequencing anomalies and were excluded by the second analysis pipeline, whereas the missense variants in MCM4, Melanocortin 2 receptor (MC2R), Nicotinamide nucleotide transhydrogenase (NNT), Steroidogenic acute regulatory protein (STAR), Cytochrome P450 11A1 (CYP11A1), MC2R accessory protein (MRAP), Thioredoxin reductase 2 (TXNRD2), and achalasia adrenal (AAAS) seen in patients 37–43 were confirmed by Sanger sequencing

Read more

Summary

Introduction

The hypothalamic–pituitary–adrenal (HPA) axis is essential in the physiological response to stress and illness. Key: HGMD, Human Gene Mutation Database; EVS, Exome Variant Server, NHLBI Exome Sequencing Project (ESP), Seattle, WA; SNV, single nucleotide variant; PAI, primary adrenal insufficiency; *, stop gain; ?, query.

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.